Stocks and Investing Stocks and Investing
Tue, April 13, 2021
[ 12:00 AM ] - WOPRAI
Sheila Kahyaoglu Maintained (TXT) at Strong Buy and Held Target at $70 on, Apr 13th, 2021
[ 12:00 AM ] - WOPRAI
Nicole Deblase Maintained (TT) at Hold with Increased Target to $157 on, Apr 13th, 2021
[ 12:00 AM ] - WOPRAI
Michael Dudas Initiated (TTEK) at Hold and Held Target at $29 on, Apr 13th, 2021
[ 12:00 AM ] - WOPRAI
Christopher Stathoulopoulos Maintained (UAL) at H .. d with Increased Target to $62 on, Apr 13th, 2021
[ 12:00 AM ] - WOPRAI
Dana Telsey Maintained (URBN) at Buy with Increased Target to $45 on, Apr 13th, 2021
[ 12:00 AM ] - WOPRAI
Kimberly Greenberger Maintained (URBN) at Buy with Increased Target to $44 on, Apr 13th, 2021
[ 12:00 AM ] - WOPRAI
Brad Heffern Maintained (UDR) at Hold and Held Target at $45 on, Apr 13th, 2021
[ 12:00 AM ] - WOPRAI
Roger Read Maintained (YUM) at Buy with Increased Target to $134 on, Apr 13th, 2021
[ 12:00 AM ] - WOPRAI
Robyn Karnauskas Initiated (TIL) at Strong Buy and Held Target at $640 on, Apr 13th, 2021
[ 12:00 AM ] - WOPRAI
Yaron Werber Initiated (TIL) at Buy on, Apr 13th, 2021
[ 12:00 AM ] - WOPRAI
Vikram Purohit Initiated (TIL) at Hold and Held Target at $480 on, Apr 13th, 2021
[ 12:00 AM ] - WOPRAI
Nicole Deblase Maintained (SWK) at Strong Buy with Increased Target to $221 on, Apr 13th, 2021
[ 12:00 AM ] - WOPRAI
Greg Badishkanian Initiated (STZ) at Buy and Held Target at $265 on, Apr 13th, 2021
[ 12:00 AM ] - WOPRAI
David Steinberg Upgraded (SUPN) to Strong Buy and Increased Target to $40 on, Apr 13th, 2021
[ 12:00 AM ] - WOPRAI
Mayank Tandon Maintained (SQ) at Strong Buy with Increased Target to $310 on, Apr 13th, 2021
[ 12:00 AM ] - WOPRAI
Gabriel Gusan Downgraded (STNE) to Hold on, Apr 13th, 2021
[ 12:00 AM ] - WOPRAI
Bobby Burleson Initiated (STKL) at Strong Buy and Held Target at $20 on, Apr 13th, 2021
[ 12:00 AM ] - WOPRAI
Steve Barger Maintained (AME) at Buy with Increased Target to $141 on, Apr 13th, 2021
[ 12:00 AM ] - WOPRAI
Michael Rose Downgraded (CADE) to Hold on, Apr 13th, 2021
[ 12:00 AM ] - WOPRAI
Jon Arfstrom Downgraded (CADE) to Hold and Increased Target to $25 on, Apr 13th, 2021
[ 12:00 AM ] - WOPRAI
Jennifer Demba Downgraded (CADE) to Hold on, Apr 13th, 2021
[ 12:00 AM ] - WOPRAI
Betsy Graseck Maintained (C) at Buy with Increased Target to $89 on, Apr 13th, 2021
[ 12:00 AM ] - WOPRAI
Greg Badishkanian Initiated (CAT) at Buy and Held Target at $265 on, Apr 13th, 2021
[ 12:00 AM ] - WOPRAI
Nicole Deblase Maintained (CAT) at Strong Buy with Increased Target to $259 on, Apr 13th, 2021
[ 12:00 AM ] - WOPRAI
Brent Thill Upgraded (BKNG) to Strong Buy on, Apr 13th, 2021
[ 12:00 AM ] - WOPRAI
Gregg Gilbert Upgraded (BMY) to Strong Buy and Increased Target to $74 on, Apr 13th, 2021
[ 12:00 AM ] - WOPRAI
Douglas Harned Initiated (SPCE) at Hold and Held Target at $540 on, Apr 13th, 2021
[ 12:00 AM ] - WOPRAI
Chris Howerton Initiated (VERU) at Strong Buy and Held Target at $19 on, Apr 13th, 2021
[ 12:00 AM ] - WOPRAI
Nicole Deblase Maintained (URI) at Hold with Increased Target to $348 on, Apr 13th, 2021
[ 12:00 AM ] - WOPRAI
Matthew Harrison Maintained (TSHA) at Buy with Increased Target to $43 on, Apr 13th, 2021

Matthew Harrison Maintained (TSHA) at Buy with Increased Target to $43 on, Apr 13th, 2021


Published on 2024-10-27 16:12:41 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Taysha Gene Therapies, Inc." (TSHA) at Buy with Increased Target from $30 to $43 on, Apr 13th, 2021.

Matthew has made no other calls on TSHA in the last 4 months.



There are 2 other peers that have a rating on TSHA. Out of the 2 peers that are also analyzing TSHA, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Matthew

  • Raju Prasad of "William Blair" Initiated at Buy and Held Target at $46 on, Wednesday, February 24th, 2021
  • Kevin DeGeeter of "Oppenheimer" Initiated at Buy on, Tuesday, January 5th, 2021
Contributing Sources